Yelda Kaya, MBBS, LLB, MBA
Chief Business Officer
Dr Kaya brings over 15 years of international business development leadership and expertise across multiple modalities, therapeutic areas and life science sectors.
Prior to joining Prellis in 2021, Yelda led complex R&D licensing, M&A and collaboration transactions as well as successful NewCo creation on behalf of Janssen at Johnson & Johnson Innovation California and GlaxoSmithKline in London, facilitating access to and further development of cutting edge pre-clinical and clinical stage technologies discovered and developed by pharma, biotech companies and institutions.
Yelda began her career as an emergency medicine clinician and M&A lawyer in Melbourne, Australia.